Literature DB >> 29193850

Olfactory loss in chronic rhinosinusitis is associated with neuronal activation of c-Jun N-terminal kinase.

Andrew J Victores1, Mengfei Chen1, Amy Smith1, Andrew P Lane1.   

Abstract

BACKGROUND: Olfactory inflammation in chronic rhinosinusitis (CRS) is associated with cytokines that may result in the death of olfactory sensory neurons. The principal signaling molecules involved in the apoptotic pathway are c-Jun N-terminal kinases (JNK). Although the JNK pathway has emerged as a key player in programmed cell death in neuroinflammation, its specific role in CRS-associated olfactory loss has not been thoroughly investigated.
METHODS: JNK activation was studied in human tissue samples from 9 control and 11 CRS patients by immunohistochemical staining for phosphorylated c-Jun. A mouse model of inducible olfactory cytokine expression was used to experimentally control inflammation and assess JNK activation over time.
RESULTS: In patients with CRS, activation of c-Jun is significantly increased relative to non-CRS control subjects, and there is an associated loss of sensory neurons. In the olfactory inflammation mouse model, prolonged induction of inflammation results in elevation of c-Jun expression and neuronal apoptosis.
CONCLUSION: Activation of neuronal JNK is a feature of chronic olfactory inflammation that is associated with neuronal apoptosis. Given that inhibition of JNK activity is neuroprotective in other settings, antagonism of this pathway may have therapeutic potential in the management of inflammatory olfactory loss or other disorders linked to olfactory neuronal apoptosis.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  JNK; chronic rhinosinusitis; inflammation; olfaction, olfactory disorders; olfactory sensory neurons

Mesh:

Substances:

Year:  2017        PMID: 29193850      PMCID: PMC5842118          DOI: 10.1002/alr.22053

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  43 in total

Review 1.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

2.  Conductive olfactory losses in chronic rhinosinusitis? A computational fluid dynamics study of 29 patients.

Authors:  Kai Zhao; Jianbo Jiang; Edmund A Pribitkin; Pamela Dalton; David Rosen; Brian Lyman; Karen K Yee; Nancy E Rawson; Beverly J Cowart
Journal:  Int Forum Allergy Rhinol       Date:  2014-01-21       Impact factor: 3.858

3.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

4.  Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis.

Authors:  Robert E Iosif; Christine T Ekdahl; Henrik Ahlenius; Cornelis J H Pronk; Sara Bonde; Zaal Kokaia; Sten-Eirik W Jacobsen; Olle Lindvall
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

5.  Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa.

Authors:  R C Kern
Journal:  Laryngoscope       Date:  2000-07       Impact factor: 3.325

6.  Olfactory mucosal findings in patients with persistent anosmia after endoscopic sinus surgery.

Authors:  S H Lee; H H Lim; H M Lee; H J Park; J O Choi
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-08       Impact factor: 1.547

7.  Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32).

Authors:  Y Suzuki; A I Farbman
Journal:  Exp Neurol       Date:  2000-09       Impact factor: 5.330

Review 8.  The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies.

Authors:  Ralph N Abi-Hachem; Azel Zine; Thomas R Van De Water
Journal:  Recent Pat CNS Drug Discov       Date:  2010-06

9.  Steroid-dependent anosmia.

Authors:  B W Jafek; D T Moran; P M Eller; J C Rowley; T B Jafek
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-05

10.  Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study.

Authors:  Markus Suckfuell; Grazyna Lisowska; Wojciech Domka; Anna Kabacinska; Krzysztof Morawski; Robert Bodlaj; Petr Klimak; Rom Kostrica; Thomas Meyer
Journal:  Otol Neurotol       Date:  2014-09       Impact factor: 2.311

View more
  5 in total

Review 1.  Temporary olfactory improvement in chronic rhinosinusitis with nasal polyps after treatment.

Authors:  Dawei Wu; Benjamin S Bleier; Yongxiang Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-19       Impact factor: 2.503

Review 2.  Immune responses in the injured olfactory and gustatory systems: a role in olfactory receptor neuron and taste bud regeneration?

Authors:  Hari G Lakshmanan; Elayna Miller; AnnElizabeth White-Canale; Lynnette P McCluskey
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 4.985

3.  Inhibition of focal adhesion kinase increases adult olfactory stem cell self-renewal and neuroregeneration through ciliary neurotrophic factor.

Authors:  Cuihong Jia; Joe Oliver; Dustin Gilmer; Chiharu Lovins; Diego J Rodriguez-Gil; Theo Hagg
Journal:  Stem Cell Res       Date:  2020-10-23       Impact factor: 2.020

4.  Expansion of murine and human olfactory epithelium/mucosa colonies and generation of mature olfactory sensory neurons under chemically defined conditions.

Authors:  Wenwen Ren; Li Wang; Xiujuan Zhang; Xiaoyu Feng; Liujing Zhuang; Nan Jiang; Rui Xu; Xuewen Li; Ping Wang; Xicai Sun; Hongmeng Yu; Yiqun Yu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 5.  Studies on Clinical Features, Mechanisms, and Management of Olfactory Dysfunction Secondary to Chronic Rhinosinusitis.

Authors:  Yi-Tsen Lin; Te-Huei Yeh
Journal:  Front Allergy       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.